small number of heterozygotes were present in the genotyped sample (n = 18) we excluded these individuals from further analysis.
Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder Recently a study in Molecular Psychiatry reported an association between neuroanatomical endophenotype and val66met brain-derived neurotrophic factor (BDNF) polymorphism. The val/val homozygotes had larger hippocampal volumes than the val/met heterozygotes and such relationship was stronger in schizophrenic patients than in control subjects. 1 We previously observed an association between this polymorphism and cognitive endophenotype (performance on the Wisconsin Card Sorting Test -WCST) in bipolar patients, where the val/val homozygotes scored better on this test than the val/met heterozygotes. 2 We extended this research to a greater number of bipolar patients as well as to schizophrenic and control subjects and found that this association is specific to bipolar illness and does not occur either in schizophrenic patients or in controls.
The analysis was performed on 111 patients with bipolar mood disorder (37 male, 74 female), aged 18-72 (mean 43) years, with the mean onset of illness 31712 years, and on 129 schizophrenic patients (66 male, 63 female), aged 18-65 (mean 27) years, with the mean onset of illness 2376 years. All patients were hospitalized at inpatient clinic, Department of Adult Psychiatry, Poznan University of Medical Sciences. In all, 92 healthy control subjects were also studied (34 male, 58 female) aged 19-58 (mean 31) Letters to the Editor years, with no history of mental illness or substance abuse. The mean duration of education was 1372 years, 1272 years and 1573 years, in bipolar, schizophrenic and control subjects, respectively. The whole group of subjects came from only one region of Poland and was ethnically homogenous. The WCST assesses working memory and executive functions, mostly connected with prefrontal lobe activity. Five domains of WCST were measured, reflecting various aspects of cognitive functions: (1) the percentage of perseverative errors (WCST-P): inability to change the reaction due to ignorance of relevant stimuli; (2) the percentage of nonperseverative errors (WCST -NP): attention inability to avoid distraction; (3) the number of correctly completed categories (WCST -CC): ability to utilize new information and previous experiences; (4) the percentage of conceptual level responses (WCST -%CONC): ability of conceptual thinking; (5) the set to the first category (WCST-1st CAT): ability to formulate a logical conception.
In bipolar patients, WCST was performed during either euthymia or mild depression, the intensity of which was less than 18 points on 17-item Hamilton Depression Scale. Patients were receiving low or middle doses of antidepressant or/and mood-normalizing drugs and none of them has been treated with ECT within the 3 years prior to the study. In schizophrenics, the severity of symptoms at the day of the study was mild (PANSS score p60 p), and the dose of the drug was not higher than 200 mg of chlorpromazine equivalent.
The genotyping of val66met polymorphism was done with PCR method as described by Neves-Pereira et al. 3 Since the frequency of the met/met genotype was minimal (2.7% in bipolar, 8.5% in schizophrenia, 3.6% in healthy controls), in statistical analysis, the groups with met/val and met/met genotypes were combined. The level of statistical significance was established as P < 0.05, and after Bonferroni correction for five subtests on WCST, the results were considered significant when P < 0.01.
Overall, in all domains of WCST bipolar patients scored intermediate between control subjects and schizophrenic patients, the latter showing marked impairment on this test. Bipolar subjects with the val/val genotype made significantly less perseverative errors, had more corrected categories and conceptual responses compared to bipolar patients with the val/met þ met/met genotypes. A numerical difference between these genotypes on WCST 1st CAT did not reach assumed significance (P < 0.02). No differences were observed in the groups of schizophrenic and control subjects ( Table 1) .
The specific association of prefrontal test performance in bipolar illness with BDNF val66met polymorphism is intriguing. In the study of Egan et al., 4 it was shown that val allele of val66met BDNF polymorphism was associated with higher activity of BDNF system. Molecular-genetic studies showed an association of val/val genotype with cognitive advantage related to hippocampal function, in schizophrenia and control subjects. 1, 5 Recent data show that val66met BDNF polymorphism may also affect prefrontal cortex structure. 6 However, we are not aware of any other cognitive studies of prefrontal cortex function in relation to this polymorphism, performed either in patients or in healthy subjects. BDNF gene is one of the strongest candidate genes for the vulnerability to bipolar illness but not to schizophrenia. 7 All positive studies using val66met BDNF polymorphism point to an association of the predisposition to bipolar illness with val allele. 3, [8] [9] [10] In conclusion, val allele of BDNF val66met polymorphism may be associated with predisposition to bipolar illness. On the other hand, specifically in bipolar patients, this allele predisposes to better performance on cognitive test measuring complex functions of prefrontal cortex. It may be speculated that this could be a part of an evolutionary trade-off of bipolar genotype. Values given as means7s.d. Difference between val/val vs val/met þ met/met significant *P < 0.01; **P < 0.005.
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